Vinorelbine in Treating Older Women With Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2006

Study Completion Date

August 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

vinorelbine tartrate

Trial Locations (18)

48106

CCOP - Ann Arbor Regional, Ann Arbor

55416

CCOP - Metro-Minnesota, Saint Louis Park

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Health Plaza, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00022152 - Vinorelbine in Treating Older Women With Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter